Physician

Kristi Kay Mckinney, M.D.

According to 2025 Medicare claims, Kristi Mckinney, M.D. (NPI: 1386627545) practices allergy/immunology in the Tacoma-Lakewood, WA market, with the plurality of this provider's patient population coming from Pierce, WA. This provider's primary affiliated billing organization is ALLERGY & ASTHMA SPECIALTY SERVICE PS (NPI: 1457461410; TIN: 911535959) and primary practice location at 98499-3024. Mckinney is affiliated with the MultiCare Connected Care, LLC (ACO ID: A3631) and Jefferson Accountable Care, LLC (ACO ID: A5275), participating under the MSSP model.

Mckinney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 371 traditional Medicare patients, billed 7,932 HCPCS/CPT codes, and received $114,611 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 665 prescription claims across 136 beneficiaries totaling $162,036 in drug costs, led by Tezspire (Tezepelumab-Ekko). DME data shows 35 claims. Open Payments data shows 17 records totaling $442. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $8,216 to $114,611. Similarly, Part D prescription costs have moved sharply higher in recent years, from $23,256 to $162,036. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $343 and ending at $1,203.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	184	864	$8,216
2017	361	6,291	$69,838
2018	416	7,550	$89,456
2019	376	7,135	$85,854
2020	373	7,342	$84,901
2021	354	6,955	$87,354
2022	365	5,465	$73,296
2023	373	6,410	$80,984
2024	371	7,932	$114,611

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	61	179	$23,256
2016	78	299	$47,043
2017	97	409	$65,879
2018	94	504	$72,598
2019	99	442	$65,877
2020	97	447	$84,926
2021	97	479	$131,396
2022	94	488	$133,072
2023	116	492	$138,417
2024	136	665	$162,036

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	37	$7,405
2017	N/R	65	$41,513
2018	N/R	173	$45,881
2019	N/R	112	$1,271
2020	N/R	50	$726
2021	N/R	12	$8,937
2022	N/R	N/R	N/R
2023	N/R	54	$22,879
2024	N/R	35	$55,073

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	172	221	$87
94010	Test to measure expiratory airflow and volume	95	117	$19
95165	Professional service for preparation and provision of 1 or more antigens	68	2,582	$11
95117	Professional service for multiple injections of allergen	85	376	$9
95115	Professional service for single injection of allergen	107	566	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tezspire	Tezepelumab-Ekko	12	336	$54,115
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	540	$11,530
Breo Ellipta	Fluticasone/Vilanterol	18	720	$9,533
Dulera	Mometasone/Formoterol	16	720	$8,114
Arnuity Ellipta	Fluticasone Furoate	27	1,050	$8,006

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	12	$53,921
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	12	$923
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	11	$229

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$442	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kristi Kay Mckinney, M.D.?

Tedicare shows public-source Medicare data for Kristi Kay Mckinney, M.D. (NPI 1386627545), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kristi Kay Mckinney, M.D. have ACO affiliation data?

Kristi Kay Mckinney, M.D. is shown with ACO affiliation data for MultiCare Connected Care, LLC (MSSP, ACO ID A3631) and Jefferson Accountable Care, LLC (MSSP, ACO ID A5275).

What billing organization is linked to Kristi Kay Mckinney, M.D.?

Kristi Kay Mckinney, M.D. is linked to ALLERGY & ASTHMA SPECIALTY SERVICE PS (billing NPI 1457461410) in the available physician profile data.

Does Kristi Kay Mckinney, M.D. have Open Payments data?

Kristi Kay Mckinney, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.